Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Zurawski

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccineSarah Conway, Shrishti Saxena, Clare Baecher-Allan, et al.
Neuron|March 30, 2010
Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant miceSarah E Ross, Alan R Mardinly, Alejandra E McCord, et al.
Frontiers in Immunology|December 12, 2022
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjectsTanuja Chitnis, Belinda J Kaskow, Junning Case, et al.
Brain Communications|October 24, 2024
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis CooperativeDaniel M Harrison, Pascal Sati, Eric C Klawiter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccineSarah Conway, Shrishti Saxena, Clare Baecher-Allan, et al.
Neuron|March 30, 2010
Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant miceSarah E Ross, Alan R Mardinly, Alejandra E McCord, et al.
Frontiers in Immunology|December 12, 2022
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjectsTanuja Chitnis, Belinda J Kaskow, Junning Case, et al.
Brain Communications|October 24, 2024
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis CooperativeDaniel M Harrison, Pascal Sati, Eric C Klawiter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
Pageof 4